Study EV-103 cohort L: Evaluating perioperative enfortumab vedotin monotherapy in cis-ineligible muscle invasive bladder cancer (MIBC) (trial in progress). Hoimes, C. J., Flaig, T. W., Srinivas, S., Mar, N., Petrylak, D. P., O'Donnell, P. H., Bilen, M., Sasse, C., Yu, Y., Birrenkott, M., Rosenberg, J. E. LIPPINCOTT WILLIAMS & WILKINS. 2022

View details for DOI 10.1200/JCO.2022.40.6_suppl.TPS587

View details for Web of Science ID 000771008900593